IP Library Patent Application 11608542
Patent Application
App. No. 11/608,542

CULTURE CELLS FROM PANCREATIC ISLETS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/608,542
Abstract

A cell composition of endocrine progenitor cells derived from mammalian pancreatic islet cells that can be trans-planted planted into a diabetic patient such t the cells of the cell composition differentiates into functioning insulin-producing beta cells.

Claims (4)

1 - 3 . (canceled)

4 . A method for implanting cells functioning as insulin-producing beta cells into a patient with diabetes, comprising:

(a) serially culturing cells derived from human mammalian pancreas islet cells in a defined cultured medium to expand the cells and to produce endocrine precursor cells in the absence of fibroblast overgrowth, wherein the defined culture medium comprises amino acids, growth factors, hormones, and lipids in the absence of serum or organ extracts, and wherein the endocrine precursor cells have less differentiation than the initially cultured cells and wherein the endocrine precursor cells express markers pdx1 and nestin; and

(b) implanting the endocrine precursor cells into a recipient patient with diabetes.

Assignments (3)
TERMINATION AND RELEASE OF PATENT SECURITY AGREEMENT Recorded Aug 6, 2021
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 057112/0677 →
SECURITY INTEREST Recorded Jun 19, 2018
From: ORGANOGENESIS INC.
To: SILICON VALLEY BANK
Reel/Frame 046392/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2006
From: JIN, JIANJIAN
To: ORGANOGENESIS, INC.
Reel/Frame 018604/0611 →